您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > Mifepristone-d3
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Mifepristone-d3
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Mifepristone-d3图片
规格:98%
分子量:432.6
包装与价格:
包装价格(元)
500ug电议
1mg电议

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx22950
CAS:N/A
分子式:C29H32D3NO2
分子量:432.6
溶解度:Chloroform: Soluble,Methanol: Soluble
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Mifepristone-d3is intended for use as an internal standard for the quantification of mifepristone by GC- or LC-MS. Mifepristone is an antagonist of glucocorticoid, progesterone, and androgen receptors (Kis = 0.1, 0.64, and 0.65 nM, respectively).1,2,3It is selective for these receptors over the mineralocorticoid receptor (MR), estrogen receptor α (ERα), and ERβ (Kis = 640, >200, and >750 nM, respectively).1In cell-based assays, mifepristone inhibits alkaline phosphatase activity stimulated by the progesterone receptor agonist R5020 as well as reporter transcription stimulated by either dexamethasone or R5020 (IC50s = 7, 5.9, and 1.3 nM, respectively).3It also inhibits synthetic androgen R1881-stimulated reporter transcription in a concentration-dependent manner.2Mifepristone (10 µM) inhibits growth of 4-OHT-resistant MCF-7 breast cancer cellsin vitro.4It also inhibits tumor growth in an SKOV3 ovarian cancer nude mouse xenograft model when administered at doses of 0.5 or 1 mg per day.5Formulations containing mifepristone have been used for the induction of medical abortions.


1.von Gerldern, T.W., Tu, N., Kym, P.R., et al.Liver-selective glucocorticoid antagonists: A novel treatment for type 2 diabetesJ. Med. Chem.47(17)4213-4230(2004) 2.Song, L.-N., Coghlan, M.J., and Gelmann, E.P.Antiandrogen effects of mifepristone on coactivator and corepressor interactions with the androgen receptorMol. Endocrinol.18(1)70-85(2004) 3.Attardi, B.J., Burgenson, J., Hild, S.A., et al.In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristoneJ. Steroid Biochem. Mol. Biol.88(3)277-288(2004) 4.Gaddy, V.T., Barrett, J.T., Delk, J.N., et al.Mifepristone induces growth arrest, caspase activation, and apoptosis of estrogen receptor-expressing, antiestrogen-resistant breast cancer cellsClinical Cancer Research105215-5225(2004) 5.Goyeneche, A.A., CarÓn, R.W., and Telleria, C.M.Mifepristone inhibits ovarian cancer cell growth in vitro and in vivoClin. Cancer Res.13(11)3370-3379(2007)